Siegfried, Jill M <br/><br/>
Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung.  [electronic resource] 

 -  Chest  May 2004 
 - 116S-9S p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0012-3692 
<br/><br/><label>Standard No.: </label>10.1378/chest.125.5_suppl.116s  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--chemistry<br/>Hepatocyte Growth Factor--analysis<br/>Humans<br/>Lung Neoplasms--chemistry<br/>Multivariate Analysis<br/>Neoplasm Staging<br/>Prognosis<br/>Survival Analysis<br/>Survival Rate